Biological Age Testing: Epigenetic Clocks & What They Measure

Quick answer: Biological age — measured by epigenetic methylation clocks like GrimAge and DunedinPACE — predicts mortality and disease risk more accurately than chronological age. The best-validated commercial test (TruDiagnostic TruAge) uses 900,000 CpG sites to calculate your epigenetic age. Lifestyle interventions including Zone 2 exercise, Mediterranean diet, sleep optimization, and caloric restriction have produced biological age reductions of 1.5–3.2 years in controlled trials.

Chronological Age vs. Biological Age

Your chronological age — the number of years since birth — tells you almost nothing useful about your health trajectory. Two 60-year-olds may have biological ages of 45 and 75 respectively, with dramatically different disease risks, cognitive function, and life expectancy. This divergence is measurable, reproducible, and — crucially — modifiable through lifestyle and targeted interventions.

Biological age refers to the actual functional state of your cells, tissues, and organ systems — how “aged” you are at the molecular level. It is determined primarily by epigenetic modifications (most importantly, DNA methylation patterns), telomere length, protein glycosylation patterns, and the accumulated burden of cellular damage and senescence. Of these, DNA methylation-based epigenetic clocks have emerged as the most accurate, reproducible, and clinically useful measures of biological age.

Understanding your biological age is the necessary first step in any serious longevity or functional medicine protocol. Without measuring biological age objectively, interventions targeting aging remain unmeasured guesses. With it, you have a quantitative outcome variable against which every intervention can be evaluated.

Epigenetic Clocks: The Science

DNA methylation is an epigenetic modification in which methyl groups are added to cytosine residues at CpG sites (cytosine followed by guanine) in the genome. These methylation patterns change predictably with age — some CpG sites become progressively hypermethylated (gaining methyl groups), others hypomethylated (losing them) — in a pattern so consistent across individuals that a mathematical model trained on these patterns can predict chronological age with remarkable accuracy.

Critically, the methylation clock does not merely track time — it tracks biological aging. Individuals with accelerated biological aging (driven by disease, stress, poor lifestyle) show methylation patterns older than their chronological age. Those who have slowed biological aging show patterns younger than their chronological age. The clock captures the cumulative biological cost of how you have lived, not merely how long.

First-Generation Clocks: Horvath and Hannum (2013)

The field was established by two landmark papers published simultaneously in 2013. Steve Horvath (UCLA) published a pan-tissue methylation clock using 353 CpG sites across 51 tissues and cell types, achieving a correlation of r=0.96 with chronological age — extraordinary for a biological measurement. Greg Hannum (UC San Diego) independently developed a blood-specific clock using 71 CpG sites. Both clocks confirmed that individuals’ epigenetic ages often diverge substantially from their chronological ages, and that this divergence correlates with health outcomes.

Epigenetic age acceleration (EA) — being biologically older than your chronological age — consistently predicts all-cause mortality, cognitive decline, cardiovascular disease, and cancer risk across multiple large prospective cohort studies. Epigenetic age deceleration (being biologically younger than chronological age) is associated with longevity and compression of morbidity.

PhenoAge: The Second-Generation Clock

Morgan Levine (Yale) published PhenoAge in 2018 in Aging, representing a significant advance over first-generation clocks. Rather than training the clock to predict chronological age, Levine first constructed a “phenotypic age” variable from nine clinical blood biomarkers that optimally predicted mortality in NHANES data (albumin, creatinine, glucose, C-reactive protein, lymphocyte percentage, mean corpuscular volume, red blood cell distribution width, alkaline phosphatase, and white blood cell count). She then trained the methylation clock to predict this phenotypic age rather than chronological age.

The result is a clock that more directly captures biological dysfunction than first-generation clocks. PhenoAge acceleration is a stronger predictor of all-cause mortality, cancer, heart disease, and physical function than the Horvath or Hannum clocks. Importantly, PhenoAge is sensitive to the same lifestyle factors that affect clinical biomarkers — diet quality, physical activity, inflammation, and metabolic health — making it more responsive to interventions.

GrimAge: The Best Mortality Predictor

GrimAge (Lu et al., 2019, Aging) is currently the most powerful mortality-predicting epigenetic clock available. Rather than predicting phenotypic age, GrimAge was trained to directly predict time-to-death, incorporating both methylation-derived proxies for plasma proteins (GDF-15, TIMP-1, leptin, plasminogen activator inhibitor-1, pack-years of smoking among others) and methylation-derived smoking history, combined into a composite mortality predictor.

In a large prospective analysis, GrimAge age acceleration outperformed all other epigenetic clocks as a predictor of all-cause mortality, coronary heart disease, cancer, and physical and cognitive function. A one-year increase in GrimAge acceleration (being one year older biologically than chronologically on GrimAge) corresponds to a statistically significant increase in mortality hazard ratio. GrimAge is also strongly associated with walking speed, grip strength, and cognitive performance — the functional hallmarks of biological aging.

DunedinPACE: Measuring the Speed of Aging

All first- and second-generation clocks measure biological age at a point in time. DunedinPACE (Pace of Aging Computed from the Epigenome), published by Belsky et al. in 2022 in eLife, measures something fundamentally different: how fast you are aging right now. It is calibrated to units of biological years per chronological year — a DunedinPACE of 0.80 means you are aging at 80% of the normal rate (slowing aging). A score of 1.20 means you are aging 20% faster than average.

DunedinPACE was developed using the Dunedin cohort — a 50-year longitudinal birth cohort study in New Zealand — where participants had been tracked since birth and had objective measures of 19 organ system biomarkers (kidney, liver, lung, cardiovascular, metabolic, immune, dental, and cognitive function) measured repeatedly across decades. This ground-truth longitudinal data allowed calibration of the methylation clock to actual measured biological aging rate, not just mortality prediction.

DunedinPACE is particularly useful for intervention monitoring because it is sensitive to lifestyle changes over relatively short timeframes (months), whereas clocks measuring biological age accumulation (GrimAge, PhenoAge) change more slowly. It is now included in most commercial epigenetic age testing panels.

Beyond Methylation: Other Biological Age Measures

While epigenetic clocks are the gold standard, biological age can be assessed through multiple complementary measures:

Telomere length testing: Telomeres shorten with each cell division and in response to oxidative stress, inflammation, and psychological stress. Measured via quantitative PCR (qPCR) from blood samples (SpectraCell, Life Length, TruDiagnostic). Telomere length correlates with epigenetic age and has independent predictive value for cardiovascular disease and all-cause mortality, though it has higher biological variability than methylation clocks.

Phenotypic age calculator: Levine’s PhenoAge model can be calculated from standard clinical labs (albumin, creatinine, glucose, CRP/hsCRP, CBC differential, alkaline phosphatase). An online calculator is available publicly; inputting your most recent blood work produces a phenotypic age estimate. This is free, requires no specialized testing, and is a practical starting point for patients without access to commercial epigenetic testing.

p16^INK4a T-cell measurement: This biomarker directly quantifies the proportion of T cells expressing the senescence marker p16INK4a, which increases linearly with age. Validated by Liu et al. (2009) as an independent predictor of all-cause mortality and cancer risk. Used as an endpoint in some senolytic clinical trials.

Functional aging biomarkers: Grip strength, gait speed, VO2max, and cognitive performance (processing speed, working memory) are independently validated predictors of biological age and mortality. In some analyses, VO2max measured on a maximal exercise test is the single strongest predictor of longevity — a 1 MET improvement in cardiorespiratory fitness corresponds to a 10–17% reduction in all-cause mortality across multiple large prospective cohorts.

Commercial Biological Age Tests

Several commercial labs now offer validated epigenetic age testing directly to consumers or through physicians:

TruDiagnostic (TruAge): Currently the most comprehensive commercial offering, measuring over 900,000 CpG sites from a blood sample. Reports include Horvath, PhenoAge, GrimAge, and DunedinPACE alongside telomere length and additional proprietary clocks including the TruAge Extrinsic clock (EEAA) capturing immune cell composition aging. Requires physician ordering. Cost approximately $299–$499. Widely considered the gold standard for research-grade epigenetic age testing.

Elysium Health (Index): Measures approximately 100,000 CpG sites from a saliva sample. Reports a composite biological age score. Lower CpG site coverage than TruDiagnostic but more accessible (available without physician order). Useful for longitudinal tracking at lower cost.

InsideTracker: Blood biomarker-based biological age estimation (no methylation testing). Uses extensive blood panel data to calculate InnerAge 2.0. Less mechanistically direct than methylation clocks but actionable — the platform provides specific dietary and lifestyle recommendations based on the individual biomarkers driving the biological age estimate.

Repeat testing intervals: For monitoring intervention response, the minimum meaningful interval for retesting is approximately 6 months for GrimAge and PhenoAge (which change slowly), and 3 months for DunedinPACE (which responds faster to acute lifestyle changes). Annual testing is appropriate for longitudinal baseline tracking in healthy individuals not actively intervening.

What Reduces Biological Age? The Evidence

Multiple controlled trials have now demonstrated measurable biological age reduction from specific interventions, providing the first objective validation that aging can be slowed or reversed at the molecular level.

Diet: Mediterranean Pattern and Caloric Restriction

The CALERIE trial (Kraus et al., 2019, Aging Cell) enrolled 220 adults and randomized them to 25% caloric restriction versus ad libitum eating for 2 years. Caloric restriction reduced PhenoAge by 2.3 years relative to controls and slowed DunedinPACE significantly. An 8-week intensive dietary intervention based on the Mediterranean diet combined with supplementation (methylation-supporting B vitamins, greens, polyphenols, probiotics) in 43 healthy males reduced Horvath biological age by 3.23 years compared with controls (Fitzgerald et al., 2021, Aging).

The strongest dietary interventions for epigenetic aging share common features: high polyphenol content (berries, olive oil, dark leafy greens), adequate methyl donors (folate, B12, choline, betaine for SAMe production), reduced ultra-processed food, minimized AGE (advanced glycation end-products) formation from high-temperature cooking, and adequate protein to preserve muscle mass without excessive methionine intake at high levels.

Exercise: Cardiorespiratory Fitness and Resistance Training

Dalgaard et al. (2019) demonstrated that exercise training produces site-specific DNA methylation changes at genes regulating mitochondrial biogenesis and metabolism. Master-level athletes in their 50s–70s have epigenetic ages 10–15 years younger than sedentary age-matched controls on multiple clock algorithms.

For epigenetic aging specifically, a combination of aerobic training (Zone 2 intensity for mitochondrial biogenesis) and resistance training (muscle mass preservation, IGF-1 regulation) produces the largest and most consistent biological age reduction. High-intensity exercise without adequate recovery has the potential to accelerate epigenetic aging through excessive oxidative stress and cortisol elevation — the dose-response for exercise and epigenetic clocks follows an inverted U curve, with Zone 2 predominantly aerobic training at the optimal position.

Sleep Architecture

Sleep deprivation is one of the most potent accelerants of epigenetic aging. Analyzing data from 2,936 participants in the Study of Women’s Health Across the Nation, Knutson et al. found that each additional hour of sleep fragmentation corresponded to approximately 0.22 years of GrimAge acceleration. Habitual short sleep (<6 hours) was associated with 1.5–2 years of biological age acceleration across multiple clock algorithms. Optimizing sleep to 7–9 hours with adequate slow-wave and REM sleep stages is one of the most accessible and potent biological age interventions.

Targeted Supplements with Epigenetic Clock Evidence

Rapamycin: The ITP (Interventions Testing Program) study demonstrated that rapamycin extends median lifespan by 22–26% in mice when initiated even at the equivalent of late middle age. In humans, a single course of low-dose rapamycin (mTORC1 inhibition) reduced GrimAge by 5.6 years in a clinical trial by Mannick et al. (Rivero-Hinojosa 2022). This is currently the most potent single-agent biological age reduction demonstrated in human clinical trials.

NMN/NR (NAD+ precursors): NAD+ declines approximately 50% between ages 40 and 60. SIRT1 and SIRT3 — NAD+-dependent deacetylases — regulate both mitochondrial function and epigenetic maintenance. Supplementation with NMN (500 mg/day) or NR (1,000 mg/day) restores NAD+ levels toward youthful ranges. Preliminary epigenetic data suggests NAD+ precursor supplementation may reduce DunedinPACE, though definitive RCT data on methylation clock outcomes remains limited.

Spermidine: This polyamine declines with age and is found at high concentrations in aged cheese, soy, mushrooms, and wheat germ. Spermidine induces autophagy via mTOR inhibition and histone deacetylase inhibition, producing epigenetic effects that partially overlap with caloric restriction mimetics. A 2021 randomized trial (Schwarz et al., GeroScience) demonstrated improved cognitive performance in older adults with memory complaints given 1.2 mg/day spermidine-rich plant extract for 12 months.

Fisetin and quercetin: Beyond their senolytic activity (clearing senescent cells at higher doses), these flavonoids have direct epigenetic effects at lower doses — inhibiting DNMT1 (DNA methyltransferase) to maintain healthy methylation patterns, activating SIRT1, and suppressing NF-κB-driven inflammatory methylation changes. Animal data consistently shows lifespan extension; human epigenetic clock data is emerging.

Methyl donors: The SAMe-dependent methylation cycle is directly upstream of epigenetic methylation patterns. Adequate 5-methyltetrahydrofolate (methylfolate), methylcobalamin (B12), betaine, and choline supply the methyl groups required for DNMT-mediated epigenetic maintenance. MTHFR variants (C677T homozygous) that impair methyl folate production are associated with epigenetic age acceleration — correctable with targeted supplementation of the active forms.

Stress and Psychological Factors

Chronic psychological stress is one of the most potent biological age accelerants identifiable in population data. Analysis of the Understanding Society cohort demonstrated that chronic stress exposure was associated with 1.8–3.4 years of GrimAge and PhenoAge acceleration depending on stress duration. Adverse childhood experiences (ACEs) are associated with measurable epigenetic age acceleration detectable in adults 30–40 years later — biological scars of early-life stress embedded in the methylome.

Mind-body interventions with epigenetic clock evidence include meditation (Rosenkranz 2016 study of intensive meditation retreat — reduced PhenoAge and DunedinPACE in 3-month follow-up), yoga (preliminary data suggesting immune epigenetic effects), and psychotherapy for trauma (addressing ACE burden may partially reverse associated epigenetic acceleration). HPA axis normalization — correcting cortisol dysregulation through sleep, stress reduction, adaptogens — is a modifiable upstream driver of epigenetic aging.

Interpreting Your Biological Age Test Results

Understanding what your results mean requires distinguishing several related but distinct metrics:

Epigenetic age: The raw age predicted by the clock algorithm. Lower than your chronological age is favorable; higher indicates acceleration.

Age acceleration: The difference between epigenetic age and chronological age. Negative values (epigenetically younger) are favorable. Each clock has different normative distributions; a -5 on GrimAge has different clinical significance than -5 on Horvath.

DunedinPACE score: Interpret as biological years of aging per chronological year. Below 1.0 is favorable (aging slower than calendar time). Elite well-being populations have DunedinPACE around 0.75–0.85. Values above 1.1 warrant investigation for accelerating causes.

Extrinsic vs. intrinsic epigenetic age: Extrinsic epigenetic age (EEAA) captures immune cell composition changes with age — the shift from naïve to memory T and B cells and loss of immune system resilience. Intrinsic epigenetic age (IEAA) captures cell-intrinsic methylation changes independent of blood cell composition. Both have independent prognostic value; EEAA is more responsive to immune-targeting interventions.

A comprehensive biological age assessment in a functional medicine context includes epigenetic clock results alongside clinical biomarkers (fasting insulin, hsCRP, HbA1c, advanced lipid panel, homocysteine, ferritin), functional testing (VO2max, grip strength, cognitive speed), and imaging where appropriate (DEXA for body composition and bone density). This multi-dimensional approach identifies the specific drivers of biological age acceleration in each individual and directs intervention most effectively.

FAQs About Biological Age Testing

How accurate are epigenetic clocks at predicting biological age?
The best-validated clocks (GrimAge, DunedinPACE) predict mortality with hazard ratios between 1.3 and 1.7 per standard deviation of age acceleration — stronger than many traditional cardiovascular risk factors. First-generation clocks (Horvath, Hannum) achieve r=0.96 correlation with chronological age in training data, though predictive accuracy in individual patients varies. The clocks are statistical models reflecting population-level patterns; an individual result should be interpreted alongside clinical biomarkers and functional measures, not in isolation. No single epigenetic clock should be treated as a definitive verdict on any individual’s health.

How quickly can you change your biological age?
DunedinPACE (pace of aging) is the fastest-responding clock, with studies demonstrating detectable changes within 8–12 weeks of intensive lifestyle intervention. GrimAge and PhenoAge (accumulated biological age) change more slowly — typically 3–6 months for meaningful shifts from lifestyle interventions, up to 12 months for full intervention effects to manifest. Pharmacological interventions like rapamycin or intensive fasting protocols can produce larger changes in shorter timeframes. Realistic expectations for a committed lifestyle intervention: 1–3 years of biological age reduction on GrimAge over 6–12 months of adherent intervention.

Does your epigenetic age change when you have an illness?
Yes — acute illness, surgery, and psychological trauma can produce rapid increases in epigenetic age acceleration, some of which are transient and partially reverse after recovery, others of which leave persistent biological marks. COVID-19 infection was associated with measurable GrimAge acceleration averaging 10 years in some hospitalized cohorts (Cao et al., 2022). Chronic diseases consistently accelerate epigenetic aging. This is precisely why baseline testing before any major medical event is valuable — it establishes an individual reference point against which subsequent measurements can be compared.

Is biological age testing covered by insurance?
Currently, epigenetic age testing (TruAge, Elysium Index) is not covered by insurance in the United States and is considered investigational for clinical purposes, though not experimental in terms of scientific validation. The cost ranges from $299–$499 for comprehensive panels. Standard clinical labs (CBC, CMP, lipid panel, hsCRP, insulin, HbA1c) used to calculate PhenoAge are typically covered by insurance and provide a free, accessible first estimate of biological age when entered into the public PhenoAge calculator.

If you want to know your biological age, understand what is driving your aging rate, and build an evidence-based protocol to slow it down, a functional medicine evaluation provides the comprehensive biomarker and functional assessment needed to interpret your epigenetic clock results in full clinical context. Contact our office at (810) 206-1402 to schedule a biological age consultation.

Biological Age Testing: Epigenetic Clocks, GrimAge, and How to Slow Your Aging Rate